Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
DNA topological problems may cause lymphoma
Researchers from the Spanish National Cancer Research Centre (CNIO), Madrid, and the Andalusian Molecular Biology…
Gold nanoparticles detect signals from cancer cells
A novel blood test that uses gold nanoparticles to detect cancer has also been shown…
Immune therapy reduces risk of recurrence in aggressive breast cancer
An immune therapy for the most aggressive form of breast cancer can substantially reduce the…
Do we need to end the ‘war’ on cancer?
David Hauser and Richard Wassersug – The Guardian. We use so much militaristic language to describe cancer. It might be doing more harm…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.